NAFAZAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nafazair, and what generic alternatives are available?
Nafazair is a drug marketed by Bausch And Lomb and Pharmafair and is included in two NDAs.
The generic ingredient in NAFAZAIR is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAFAZAIR?
- What are the global sales for NAFAZAIR?
- What is Average Wholesale Price for NAFAZAIR?
Summary for NAFAZAIR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 91 |
| Patent Applications: | 3,408 |
| DailyMed Link: | NAFAZAIR at DailyMed |
US Patents and Regulatory Information for NAFAZAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | NAFAZAIR | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 040073-001 | May 25, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmafair | NAFAZAIR | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 088101-001 | Apr 15, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
